Wynand obtained his PhD in Biochemistry and Microbiology from Groningen. He then worked at the Karolinska Institute in Stockholm as a post-doc in bioinformatics, focusing on genome analysis of Staphylococcus aureus and the relation to multi-drug resistance. After his post-doc period he moved to the pharmaceutical industry where he had several bioinformatics positions at Organon, Schering-Plough and Merck including the lead of molecular profiling in global clinical development teams for anti-inflammatory drugs.
In 2011 he moved to NIZO to become head of the Fermentation group, where he was responsible for the acquisition and execution of all projects related to functional microbial fermentation and growth optimization.
In his current role at NIZO he is responsible for acquiring and managing (big) data analysis projects in the field of microbial genomics, predictive micro-models and microbe-host interactions in gut and skin health. Next to his function at NIZO Wynand is chair (part-time) of the Bioinformatics core facility of the Radboud University Medical center in Nijmegen.